Individuals with type 2 diabetes (T2D), characterized by impaired insulin action and enhanced glucagon secretion (hyperglucagonemia), resulting in hyperglycemia [1, 2], have a higher risk of cognitive decline [3-5]. The gene discussed is INS; the disease is type 2 diabetes mellitus.